Nearly 90,000 Bottles of Infants' Ibuprofen Recalled Over Foreign Substance Concerns

Tris Pharma, Inc. has announced a voluntary recall of approximately 89,592 bottles of infants' ibuprofen concentrated oral suspension. The recall affects several lots of the berry-flavored medication sold at major national retailers.

The products were distributed under the store brand names Equate, CVS Health, and Family Wellness. These items are sold specifically at Walmart, CVS Pharmacy, and Family Dollar stores across the United States.

The pharmaceutical company initiated the recall after discovering the potential presence of a foreign substance in certain units. Investigations revealed that a piece of a silicone valve might have contaminated the liquid during the production process.

Health experts state that the inclusion of foreign materials in the medication poses potential safety risks. This includes a possible choking hazard for infants who consume the product.

There is also concern regarding the potential for gastrointestinal injury if the foreign object is swallowed. Tris Pharma reported that it has not received any reports of adverse events related to this recall.

The specific concentration involved is 50 mg of ibuprofen per 1.25 mL. Affected products were packaged in half-ounce and one-ounce bottles intended for infants.

Consumers who have purchased these products are encouraged to check the lot numbers printed on the packaging. The company has provided specific lot numbers and expiration dates to help identify the impacted batches.

The U.S. Food and Drug Administration is monitoring the recall process. This regulatory oversight ensures that the manufacturer follows standard procedures for removing potentially hazardous items from the marketplace.

Retailers have been instructed to stop selling the specified lots immediately. Distribution centers are also working to pull the product from their inventories to prevent further sales.

Caregivers who identify affected bottles in their homes should discontinue use. The manufacturer suggests contacting a healthcare provider if there are concerns about a child's health after using the medication.

Tris Pharma has established a customer service line to handle inquiries. While no injuries have been documented, the company maintains that the voluntary recall is a necessary precaution to mitigate risk.